Eye and kidney: From clinical findings to genetic explanations

Journal of the American Society of Nephrology

Volumn 14, Issue 2, 2003, Pages 516-529

  Izzedine, Hassane ^a,b   Bodaghi, Bahram ^a   Launay Vacher, Vincent ^a   Deray, Gilbert ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Department of Nephrology ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PROTEIN; PROTEIN BMP7; PROTEIN EYA1; PROTEIN PAX; PROTEIN WT1; UNCLASSIFIED DRUG;

ALPORT SYNDROME; ANIRIDIA; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BARDET BIEDL SYNDROME; CHORIORETINOPATHY; COLOBOMA; CONGENITAL MALFORMATION; ENZYME DEFECT; EYE DEVELOPMENT; KIDNEY CYST; KIDNEY DEVELOPMENT; KIDNEY MALFORMATION; KIDNEY POLYCYSTIC DISEASE; NAIL PATELLA SYNDROME; PHAKOMATOSIS; PHENOTYPE; PRIORITY JOURNAL; STURGE WEBER SYNDROME; SYNDROME CHARGE; TUBEROUS SCLEROSIS; VESICOURETERAL REFLUX; VON HIPPEL LINDAU DISEASE; ZELLWEGER SYNDROME;

EID: 0037305037     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000051705.97966.AD     Document Type: Article

References (122)

1. Pohl M, Bhatnagar V, Mendoza SA, Nigam SK: Toward an etiological classification of developmental disorders of the kidney and upper urinary tract. Kidney Int 61: 10-19, 2002
2. Dahl E, Koseki H, Balling R: Pax genes and organogenesis. Bioessays 19: 755-765, 1997
3. Mrowka C, Schedl A: Wilms' tumor suppressor gene WT1: From structure to renal pathophysiologic features. J Am Soc Nephrol 11: S106-S115, 2000
4. Wagner N, Wagner KD, Schley G, Coupland SE, Heimann H, Grantyn R, Scholz H: The wilms' tumor suppressor wt1 is associated with the differentiation of retinoblastoma cells. Cell Growth Differ 13: 297-305, 2002
5. Armstrong JF, Pritchard-Jones K, Bickmore WA, Hastie ND, Bard JB: The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech Dev 40: 85-97, 1993
6. Wang SW, Gan L, Martin SE, Klein WH: Abnormal polarization and axon outgrowth in retinal ganglion cells lacking the POU-domain transcription factor Brn-3b. Mol Cell Neurosci 16: 141-156, 2000
7. Schimmenti LA, Cunliffe HE, McNoe LA, Ward TA, French MC, Shim HH, Zhang Y-H, Proesmans W, Leys A, Byerly KA, Braddock SR, Masuno M, Imaizumi K, Devriendt K, Eccles MR: Further delineation of renal-coloboma syndrome in patients with extreme variability of phenotype and identical PAX2 mutations, Am J Hum Genet 60: 869-878, 1997
8. Devriendt K, Matthijs G, Van Damme B, Van Caesbroeck D, Eccles M, Vanrenterghem Y, Fryns J-P, Leys A: Missense mutation and hexanucleotide duplication in the PAX2 gene in two unrelated families with renal-coloboma syndrome (MIM 120330). Hum Genet 103: 149-153, 1998
9. Pagon RA: Ocular coloboma. Surv Ophthalmol 25: 223-36, 1981
10. Karcher H: Zum 'morning glory' Syndrom. Klin Mbl Augenheilk 175: 835-840, 1979
11. Weaver RG, Cashwell LF, Lorentz W, Whiteman D, Geisinger KR, Ball M: Optic nerve coloboma associated with renal disease. Am J Med Genet 29: 597-605, 1988
12. Eccles MR, Bailey RR, Abbott GD, Sullivan MJ: Unravelling the genetics of vesicoureteric reflux: A common familial disorder. Hum Mol Genet 5: 1425-1429, 1996
13. Cunliffe HE, McNoe LA, Ward TA, Devriendt K, Brunner HG, Eccles MR: The prevalence of PAX2 mutations in patients with isolated colobomas or colobomas associated with urogenital anomalies. J Med Genet 35: 806-812, 1998
14. Feather SA, Malcolm S, Woolf AS, Wright V, Blaydon D, Reid CJ, Flinter FA, Proesmans W, Devriendt K, Carter J, Warwicker P, Goodship TH, Goodship JA: Primary, nonsyndromic vesicoureteric reflux and its nephropathy is genetically heterogeneous, with a locus on chromosome 1. Am J Hum Genet 66: 1420-1425, 2000
15. Narahara K, Baker E, Ito S, Yokoyama Y, Yu S, Hewitt D, Sutherland GR, Eccles MR, Richards RI: Localisation of a 10q breakpoint within the PAX2 gene in a patient with a de novo t(10;13) translocation and optic nerve coloboma-renal disease. J Med Genet 34: 213-216, 1997
16. Dressler GR, Deutsch U, Chowdhury K, Nornes HO, Gruss P: Pax2, a new murine paired-box-containing gene and its expression in the developing excretory system. Development 109: 787-795, 1990
17. Otteson DC, Shelden E, Jones JM, Kameoka J, Hitchcock PF: Pax2 expression and retinal morphogenesis in the normal and Krd mouse. Dev Biol 193: 209-224, 1998
18. Hildebrandt F: Nephronophthisis, In: Pediatric Nephrology, edited by Barratt TM, Avner ED, Harmon WE, Philadelphia, Lippincott Williams & Wilkins 1999, pp 453-458
19. Antignac C, Kleinknecht C, Habib R: Nephronophthisis In: Oxford Textbook of Clinical Nephrology, edited by Davison AM, Cameron JS, Grünfeld JP, Kerr DNS, Ritz E, Winearls CG, Oxford, Oxford University Press, 1998, pp 2417-2426
20. Omran H, Sasmaz G, Haffner K, Volz A, Olbrich H, Melkaoui R, Otto E, Wienker TF, Korinthenberg R, Brandis M, Antignac C, Hildebrandt F: Identification of a gene locus for Senior-Loken syndrome in the region of the nephronophthisis type 3 gene. J Am Soc Nephrol 13: 75-79, 2002
21. Schuermann MJ, Otto E, Becker A, Saar K, Ruschendorf F, Polak BC, Ala-Mello S, Hoefele J, Wiedensohler A, Haller M, Omran H, Nurnberg P, Hildebrandt F: Mapping of gene loci for nephronophthisis type 4 and Senior-Loken syndrome, to chromosome 1p36. Am J Hum Genet 70: 1240-1246, 2002
22. Mollet G, Salomon R, Gribouval O, Silbermann F, Bacq D, Landthaler G, Milford D, Nayir A, Rizzoni G, Antignac C, Saunier S: The gene mutated in juvenile nephronophthisis type 4 encodes a novel protein that interacts with nephrocystin. Nat Genet 32: 300-305, 2002
23. Otto E, Hoefele J, Ruf R, Mueller AM, Hiller KS, Wolf MT, Schuermann MJ, Becker A, Birkenhager R, Sudbrak R, Hennies HC, Nurnberg P, Hildebrandt F: A gene mutated in nephronophthisis and retinitis pigmentosa encodes a novel protein, nephroretinin, conserved in evolution. Am J Hum Genet 71: 1161-1167, 2002
24. Tellier AL, Cormier-Daire V, Abadie V, Amiel J, Sigaudy S, Bonnet D, de Lonlay-Debeney P, Morrisseau-Durand MP, Hubert P, Michel JL, Jan D, Dollfus H, Baumann C, Labrune P, Lacombe D, Philip N, LeMerrer M, Briard ML, Munnich A, Lyonnet S: CHARGE syndrome: Report of 47 cases and review. Am J Med Genet 76: 402-409, 1998
25. Russell-Eggitt IM, Blake KD, Taylor DS, Wyse RK: The eye in the CHARGE association. Br J Ophthalmol 74: 421-426, 1990
26. Ragan DC, Casale AJ, Rink RC, Cain MP, Weaver DD: Genitourinary anomalies in the CHARGE association. J Urol 161: 622-625, 1999
27. Kumar S, Rankin R: Renal insufficiency is a component of COACH syndrome. Am J Med Genet 61: 122-126, 1996
28. Gronskov K, Olsen JH, Sand A, Pedersen W, Carlsen N, Bak Jylling AM, Lyngbye T, Brondum-Nielsen K, Rosenberg T: Population-based risk estimates of Wilms tumor in sporadic aniridia. A comprehensive mutation screening procedure of PAX6 identifies 80% of mutations in aniridia. Hum Genet 109: 11-18, 2001
29. Wagner KD, Wagner N, Vidal VP, Schley G, Wilhelm D, Schedl A, Englert C, Scholz H: The Wilms' tumor gene WT1 is required for normal development of the retina. EMBO J 21: 1398-1405, 2002
30. Coppes MJ, Egeler RM: Genetics of Wilms' tumor. Semin Urol Oncol 17: 2-10, 1999
31. Little M, Wells C: A clinical overview of WT1 gene mutations. Hum Mutat 9: 209-225, 1997
32. Schumacher V, Scharer K, Wuhl E, Altrogge H, Bonzel KE, Guschmann M, Neuhaus TJ, Pollastro RM, Kuwertz-Broking E, Bulla M, Tondera AM, Mundel P, Helmchen U, Waldherr R, Weirich A, Royer-Pokora B: Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations. Kidney Int 53: 1594-1600, 1998
33. Pierides AM, Athanasiou Y, Demetriou K, Koptides M, Deltas CC: A family with the branchio-oto-renal syndrome: Clinical and genetic correlations. Nephrol Dial Transplant 17: 1014-1018, 2002
34. Azuma N, Hirakiyama A, Inoue T, Asaka A, Yamada M: Mutations of a human homologue of the Drosophila eyes absent gene (EYA1) detected in patients with congenital cataracts and ocular anterior segment anomalies. Hum Mol Genet 9: 363-366, 2000
35. Ozkaynak E, Rueger DC, Drier EA, Corbett C, Ridge RJ, Sampath TK, Oppermann H: OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J 9: 2085-2093, 1990.
36. Hahn GV, Cohen RB, Wozney JM, Levitz CL, Shore EM, Zasloff MA, Kaplan FS: A bone morphogenetic protein subfamily: chromosomal localization of human genes for BMP5, BMP6, and BMP7. Genomics 14: 759-762, 1992
37. Marker PC, King JA, Copeland NG, Jenkins NA, Kingsley DM: Chromosomal localization, embryonic expression, and imprinting tests for Bmp7 on distal mouse chromosome 2. Genomics 28: 576-580, 1995
38. Saxen L, Lehtonen E: Embryonic kidney in organ culture. Differentiation 36: 2-11, 1987
39. Webster EH Jr, Silver AF, Gonsalves NI: The extracellular matrix between the optic vesicle and presumptive lens during lens morphogenesis in an anophthalmic strain of mice. Dev Biol 103: 142-1250, 1984
40. Kaufman MH: Postcranial morphological features of homozygous tetraploid mouse embryos. J Anat 180: 521-534, 1992
41. Watson GH, Miller V: Arteriohepatic dysplasia: familial pulmonary arterial stenosis with neonatal liver disease. Arch Dis Child 48: 459-466, 1973
42. Alagille D, Odievre M, Gautier M, Dommergues JP: Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental and sexual development, and cardiac murmur. J Pediat 86: 63-71, 1975
43. Spinner NB, Rand EB, Fortina P, Genin A, Taub R, Semeraro A, Piccoli DA: Cytologically balanced t(2;20) in a two-generation family with Alagille syndrome: Cytogenetic and molecular. Am J Hum Genet 55: 238-243, 1994.
44. LaBrecque DR, Mitros FA, Nathan RJ, Romanchuk KG, Judisch GF, El-Khoury GH: Four generations of arteriohepatic dysplasia. Hepatology 2: 467-474, 1982
45. Martin, SR, Garel L, Alvarez F, Alagille's syndrome associated with cystic renal disease. Arch Dis Child 74: 232-235, 1996.
46. Habib R, Dommergues JP, Gubler MC, Hadchouel M, Gautier M, Odievre M, Alagille D: Glomerular mesangiolipidosis in Alagille syndrome (arteriohepatic dysplasia). Pediatr Nephrol 1: 455-464, 1987
47. Russo PA, Ellis D, Hashida Y: Renal histopathology in Alagille's syndrome. Pediatr Pathol 7: 557-568, 1987
48. Woolfenden AR, Albers GW, Steinberg GK, Hahn JS, Johnston DCC, Farrell K: Moyamoya syndrome in children with Alagille syndrome: Additional evidence of a vasculopathy. Pediatrics 103: 505-508, 1999
49. Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, Qi M, Trask BJ, Kuo WL, Cochran J, Costa T, Pierpont MEM, Rand EB, Piccoli DA, Hood L, Spinner NB: Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nature Genet. 16: 243-251, 1997
50. Giannakudis J, Ropke A, Kujat A, Krajewska-Walasek M, Hughes H, Fryns J-P, Bankier A, Amor D, Schlicker M, Hansmann I.: Parental mosaicism of JAGI mutations in families with Alagille syndrome. Eur J Hum Genet 9: 209-216, 2001
51. McCright B, Gao X, Shen L, Lozier J, Lan Y, Maguire M, Herzlinger D, Weinmaster G, Jiang R, Gridley T: Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development 128: 491-502, 2001
52. Folz SJ, Trobe JD: The peroxisome and the eye. Surv Ophthalmol 35: 353-368, 1991
53. Ekblom P: Genetics of kidney development. Curr Opin Nephrol Hypertens 5: 282-287, 1996
54. Klein G, Langegger M, Timpl R, Ekblom P: Role of laminin A chain in the development of epithelial cell polarity. Cell 55: 331-341, 1988
55. Regenbogen LS, Eliahou HE: Diseases Affecting the Eye and the Kidney, Basel, Karger, 1993
56. Warkany J: Congenital Malformations Notes and Comments, Chicago, Year Book Medical Publishers, 1975
57. Meyrier A, Simon P: Drooping upper eyelids and polycystic kidney disease. J Am Soc Nephrol 5: 1266-1270, 1994
58. Sadler LS, Robinson LK: Chorioretinal dysplasia-microcephalymental retardation syndrome: Report of an American family. Am J Med Genet 47: 65-68, 1993
59. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75: 229-240, 1993
60. Noakes PG, Miner JH, Gautam M, Cunningham JM, Sanes JR, Merlie JP: The renal glomerulus of mice lacking s-laminin/laminin beta 2: Nephrosis despite molecular compensation by laminin beta 1. Nat Genet 10: 400-406, 1995
61. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, et al: Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269: 230-234, 1995
62. Lo SH, Yu QC, Degenstein L, Chen LB, Fuchs E: Progressive kidney degeneration in mice lacking tensin. J Cell Biol 136: 1349-1361, 1997
63. Dinchuk JE, Car BD, Focht RJ, Johnston JJ, Jaffee BD, Covington MB, Contel NR, Eng VM, Collins RJ, Czerniak PM, et al: Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378: 406-409, 1995
64. Koptides M, Deltas CC. Autosomal dominant polycystic kidney disease: Molecular genetics and molecular pathogenesis. Hum Genet 107: 115-126, 2000
65. Chauveau D, Duvic C, Chretien Y, Paraf F, Droz D, Melki P, Helenon O, Richard S, Grunfeld JP: Renal involvement in von Hippel-Lindau disease. Kidney Int 50: 944-951, 1996
66. Neumann HP, Wiestler OD: Clustering of features of von Hippel-Lindau syndrome: Evidence for a complex genetic locus. Lancet 337: 1052-1054, 1991
67. Duan DR, Pause A, Burgess WH, Aso T, Chen DY, Garrett KP, Conaway RC, Conaway JW, Linehan WM, Klausner RD: Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269: 1402-1406, 1995
68. Webster AR, Maher ER, Moore AT: Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch Ophthalmol 117: 371-378, 1999
69. Gurwin EB, Fitzsimons RB, Sehmi KS, Bird AC: Retinal telangiectasis in facioscapulohumeral muscular dystrophy with deafness. Arch Ophthalmol 103: 1695-1700, 1985
70. Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-Smith MA: Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77: 1151-1163, 1990
71. th edition, edited by Walsh PC, Philadelphia, WB Saunders, 1992, 1461-1463
72. Solomon D, Schawartz A: Renal pathology in vHL disease. Hum Pathol 19: 1072-1079, 1988
73. Sullivan TJ, Clarke MP, Morin JD: The ocular manifestations of the Sturge-Weber syndrome. J Pediatr Ophthalmol Strabismus 29: 349-56, 1992
74. Augsburger JJ, Anand R, Sanborn GE: Choroidal hemangiomas. In: Ophthalmology, edited by Yanoff M, Duker JS, London, Mosby, 1999, 1-4
75. Lee H, Choi SS, Kim SS, Hong YJ: A case of glaucoma associated with Sturge-Weber syndrome and Nevus of Ota. Korean J Ophthalmol 15: 48-53, 2001
76. Celebi S, Alagoz G, Aykan U: Ocular findings in Sturge-Weber syndrome. Eur J Ophthalmol 10: 239-243, 2000
77. Sadda SR, Miller NR, Tamargo R, Wityk R: Bilateral optic neuropathy associated with diffuse cerebral angiomatosis in Sturge-Weber syndrome. J Neuroophthalmol 20: 28-31, 2000
78. Schofield D, Zaatari GS, Gay BB: Klippel-Trenaunay and Sturge-Weber syndromes with renal hemangioma and double inferior vena cava. J Urol 136: 442-445, 1986
79. Van der Hoeve J: Les phakomatoses de Bourneville de Recklinghausen et de von Hippel-Lindau. J Belg Neurol Psychiatr 33: 752-762, 1933
80. Hyman MH, Whittemore VH: National Institutes of Health consensus conference: Tuberous sclerosis complex. Arch Neurol 57: 662-665, 2000
81. Nellist M, Brook-Carter PT, Connor JM, Kwiatkowski DJ, Johnson P, Sampson JR: Identification of markers flanking the tuberous sclerosis locus on chromosome 9 (TSC1). J Med Genet 30: 224-227, 1993
82. Gold DH, Weingeist TA. The Eye in Systemic Disease, Philadelphia, Lippincott 1990, pp 447-455
83. st edition, edited by Cameron S, Davison AM, Grünfeld JP, Kerr D, Ritz E, New York, Oxford Univsersity Press, 1992, 2143-2144
84. Okada RD, Platt MA, Fleishman J. Chronic renal failure in patients with tuberous sclerosis association with renal cysts. Nephron 30: 85-88, 1982
85. nd edition, edited by Edelmann CM Jr, Boston, Little Brown, 1992, pp 1072-1076
86. Blute ML, Malek RS, Segura JW: Angiomyolipoma: Clinical metamorphosis and concepts for management. J Urol 139: 20-24, 1988
87. Vekemans K, Van Oyen P, Denys H, Vergison R: Renal angiomyolipoma as a cause of fever of unknown origin. Br J Urol 60: 271, 1987
88. Bernstein J, Robbins TO: Renal involvement in tuberous sclerosis. Ann NY Acad Sci 615: 36-49, 1991
89. Brook-Carter PT, Peral B, Ward CJ, Thompson P et al: Deltion of the TSC-2 and PKD1 genes associated with sever infantile polycystic kidney disease: A contiguous gene syndrome. Nat Genet 8: 328-332, 1994
90. Washecka R, Hanna M: Malignant renal tumors in tuberous sclerosis. Urology 37: 340-343, 1991
91. Schillinger F, Montagnac R, Grapin JL, Schillinger D, Bressieux JM: Le rein au cours de la sclérose tubéreuse de Bourneville. Rev Med Interne 9: 61-66, 1988
92. Nagashima Y, Ohaki Y, Tanaka Y, Misugi K, Horiuchi M: A case of renal angiomyolipomas associated with multiple and various hamartomatous microlesions. Virchows Arch A Pathol Anat Histopathol 413: 177-182, 1988
93. Rolfes DB, Towbin R, Bove KE: Vascular dysplasia in a child with tuberous sclerosis. Pediabic Pathol 3: 359-373, 1985
94. Mykytyn K, Nishimura DY, Searby CC, Shastri M, Yen HJ, Beck JS, Braun T, Streb LM, Cornier AS, Cox GF, Fulton AB, Carmi R, Luleci G, Chandrasekharappa SC, Collins FS, Jacobson SG, Heckenlively JR, Weleber RG, Stone EM, Sheffield VC: Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome. Nat Genet 31: 435-438, 2002
95. Beales PL, Reid HA, Griffiths MH, Maher ER, Flinter FA, Woolf AS: Renal cancer and malformations in relatives of patients with Bardet-Biedl syndrome. Nephrol Dial Transplant 15: 1977-1985, 2000
96. Alport, AC: Hereditary familial congenital haemorrhagic nephritis. Brit Med J 1: 504-506, 1927
97. Kashtan CE, Michael AF: Alport syndrome. Kidney Int 50: 1445-1463, 1996
98. Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pirson Y, Verellen-Dumoulin C, Chan B, Schroder CH, Smeets HJ, et al: Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8: 77-81, 1994
99. Jacobs M, Jeffrey B, Kriss A, Taylor D, Sa G, Barratt TM. Ophthalmologic assessment of young patients with Alport syndrome. Ophthalmology 99: 1039-1044, 1992
100. Govan JA: Ocular manifestations of Alport's syndrome: a hereditary disorder of basement membranes? Br J Ophthalmol 67: 493-503, 1983
101. Burke JP, Clearkin LG, Talbot JF: Recurrent corneal epithelial erosions in Alport's syndrome. Acta Ophthalmol (Copenh) 69: 555-557, 1991
102. Kalluri R, Weber M, Netzer K-O, Sun MJ, Neilson EG, Hudson BG: COL4A5 gene deletion and production of post-transplant anti-alpha-3(IV) collagen alloantibodies in Alport syndrome. Kidney Int 45: 721-726, 1994
103. Milliner DS, Pierides AM, Holley KE: Renal transplantation in Alport's syndrome: Anti-glomerular basement membrane glomerulonephritis in the allograft. Mayo Clin Proc 57: 35-43, 1982
104. Richardson D, Shires M, Davison AM: Renal diagnosis without renal biopsy. Nephritis and sensorineural deafness. Nephrol Dial Transplant 16: 1291-1294, 2001
105. Ferguson-Smith MA, Aitken DA, Turleau C, de Grouchy J: Localisation of the human ABO: Np-1:AK-1 linkage group by regional assignment of AK-1 to 9q34. Hum Genet 34: 35-43, 1976
106. Singh SD, Chhaparwal BC, Dhanda RP, Pohowalla JN: A syndrome of dwarfism, mental retardation, lens opacities, nystagmus, strabismus, and cryptorchidism and absent patellae. Report of 2 cases in siblings. Indian J Pediatr 37: 197-199, 1970
107. Craig JE, Mackey DA: Glaucoma genetics: where are we? Where will we go? Curr Opin Ophthalmol 10: 126-134, 1999
108. Simila S, Vesa L, Wasz-Hockert O: Hereditary onycho-osteodysplasia (the nail-patella syndrome) with nephrosis-like renal disease in a newborn boy. Pediatrics 46: 61-65, 1970
109. Meyrier A, Rizzo R, Gubler MC: The Nail-Patella syndrome. A review. J Nephrol 2: 133-140, 1990
110. Curtis JJ, Athena DB, Leach RP, Galla JH, Lucas BA, Luke RG: Goodpasture's syndrome in a patient with the nail-patella syndrome. Am J Med 61: 401-406, 1976
111. Mackay IG, Doig A, Thomson D: Membranous nephropathy in a patient with nail-patella syndrome nephropathy. Scottish Med J 30: 47-49, 1985
112. Croodk AD, Bashar Kahaleh M, Powers JM: Vasculitis and renal disease in nail-patella syndrome: Case report and literature review. Ann Rheum Dis 46: 562-565, 1987
113. Morita T, Laughlin O, Kawano K, Kimmelstiel P: Nail-patella syndrome. Arch Intern Med 131: 271-277, 1973
114. Taguchi T, Takebayashi S, Nishimura M, Tsuru N: Nephropathy of nail-patella syndrome. Ultrastruct Path 12: 175-183, 1988
115. Looij BJ Jr, Te Slaa RL, Hogewind BL, van de Kamp JJP: Genetic counselling in hereditary osteo-onychodysplasia (HOOD, nail-patella syndrome) with nephropathy. J Med Genet 25: 682-686, 1988
116. Renwick JH, Schulze J: Male and female recombination fractions for the nail patella: ABO linkage in man. Ann Hum Genet 28: 379-392, 1965
117. Chen H, Lun Y, Ovchinnikov D, Kokubo H, Oberg KC, Pepicelli CV, Gan L, Lee B, Johnson RL: Limb and kidney defects in Lmx1b mutant mice suggest an involvement of LMX1B in human nail patella syndrome. Nature Genet 19: 51-55, 1998
118. Dreyer SD, Zhou G, Baldini A, Winterpacht A, Zabel B, Cole W, Johnson RL, Lee B: Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat Genet 19: 47-50, 1998
119. Gjone E, Blomhoff JP, Holme R, Hovig T, Olaisen B, Skarbovik AJ, Teisberg P: Familial lecithin:cholesterol acyltransferase deficiency: report of a fourth family from Northwestern Norway. Acta Med Scand 210: 3-6, 1981
120. McIntyre N: Familial LCAT deficiency and fish-eye disease. J Inher Metab Dis 11: 45-56, 1988
121. Norum KR, Gjone E, Glomset JA: Familial lecithin:cholesterol acyltransferase deficiency including fish eye disease. In: The Metabolic Basis of Inherited Disease, edited by Scriver CR, Beaudet AL, Sly WS, Valle D, New York McGraw-Hill, 1989, pp 1181-1194
122. Usui T, Hara M, Satoh H, Moriyama N, Kagaya H, Amano S, Oshika T, Ishii Y, Ibaraki N, Hara C, Kunimi M, Noiri E, Tsukamoto K, Inatomi J, Kawakami H, Endou H, Igarashi T, Goto A, Fujita T, Araie M, Seki G: Molecular basis of ocular abnormalities associated with proximal renal tubular acidosis. J Clin Invest 108: 107-115, 2001